Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
merck
3
×
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
diagnostics
immunotherapy
indiana blog main
indiana top stories
life sciences
medicare
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
sickle cell disease
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
abeona therapeutics
What
drug
3
×
patients
3
×
bio
company
roundup
acquisitions
admi
advantages
albert
altoida
approved
augmented
bar
biggest
bourla
brings
ceo
chief
crispr
developing
diseases
expect
food
founder
future
gamble
identifying
illness
imports
ioannis
maker
maps
market
measured
medco’s
mental
mover
neurodegenerative
new
nineteen
Language
unknown
unset
Current search:
drug
×
patients
×
merck
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@techcrunch.com
5 years ago
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases